Elevated circulating follistatin associates with increased risk of mortality and cardiometabolic disorders

Abstract

Elevated circulating FST associates with an increased risk of mortality and HF, which partly may be mediated by diabetes. FST also associated with stroke, ischemic stroke, CE and CKD, independently of established risk factors including diabetes.